Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-029432
Filing Date
2012-05-15
Accepted
2012-05-15 15:27:10
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v311086_10q.htm 10-Q 269117
2 EXHIBIT 31.01 v311086_ex31-01.htm EX-31.01 9901
3 EXHIBIT 31.02 v311086_ex31-02.htm EX-31.02 9913
4 EXHIBIT 32.01 v311086_ex32-01.htm EX-32.01 5089
  Complete submission text file 0001144204-12-029432.txt   1440732

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tnxp-20120331_cal.xml EX-101.CAL 21895
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tnxp-20120331_def.xml EX-101.DEF 62619
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tnxp-20120331_lab.xml EX-101.LAB 141735
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tnxp-20120331_pre.xml EX-101.PRE 85061
9 XBRL INSTANCE DOCUMENT tnxp-20120331.xml EX-101.INS 99755
10 XBRL TAXONOMY EXTENSION SCHEMA tnxp-20120331.xsd EX-101.SCH 23671
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-150149 | Film No.: 12844051
SIC: 1000 Metal Mining